MF
MDGL icon

Magnetar Financial’s Madrigal Pharmaceuticals MDGL Stock Holding History

Magnetar Financial’s Portfolio MDGL Stock Details MDGL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.99M Buy
+3,811
New +$1.82M 0.02% 317
2025
Q3 		– Sell
-6,730
Closed -$2.04M – 1060
2025
Q2 		$2.04M Buy
+6,730
New +$2.01M 0.01% 345

Other funds holding MDGL

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PC
Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Magnetar Financial's MDGL Position: Q1 2026 in Review

Magnetar Financial opened a new position in Madrigal Pharmaceuticals (MDGL) in Q1 2026: 3,811 shares worth $1.99M. The stake represents 0.02% of the portfolio and ranks #317 among its holdings. This is a return to the name: Magnetar Financial previously reported a position in MDGL as recently as Q2 2025.

Magnetar Financial first reported a position in MDGL in Q2 2025 and has held it in 2 quarters since. The position peaked at $2.04M in Q2 2025. 378 funds tracked by Wall St. Rank hold MDGL as of Q1 2026.

  • Magnetar Financial held 3,811 shares of Madrigal Pharmaceuticals worth $1.99M as of Q1 2026.
  • Madrigal Pharmaceuticals was a new Magnetar Financial position in Q1 2026.
  • Madrigal Pharmaceuticals made up 0.02% of Magnetar Financial's portfolio in Q1 2026, its #317 holding.
  • Magnetar Financial first reported a position in Madrigal Pharmaceuticals in Q2 2025 and has held it in 2 quarters since.
  • Magnetar Financial's Madrigal Pharmaceuticals position peaked at $2.04M in Q2 2025.
  • 378 funds tracked by Wall St. Rank held Madrigal Pharmaceuticals as of Q1 2026.

Based on Magnetar Financial's 13F filing for Q1 2026, filed 13 May 2026.